Rennova Health Stock Price, News & Analysis (OTCMKTS:RNVA)

$0.0056 0.00 (-6.67 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$0.01
Today's RangeN/A
52-Week RangeN/A
Volume16.98 million shs
Average Volume14.03 million shs
Market Capitalization$31,584.00
P/E Ratio0.00
Dividend YieldN/A
Beta-1.22

About Rennova Health (OTCMKTS:RNVA)

Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova's principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc.

Receive RNVA News and Ratings via Email

Sign-up to receive the latest news and ratings for RNVA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Enterprise Software
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:RNVA
CUSIPN/A
Phone+1-561-8551626

Debt

Debt-to-Equity Ratio-0.26%
Current Ratio0.11%
Quick Ratio0.10%

Price-To-Earnings

Trailing P/E Ratio-3.37980566117448E-05
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.24 million
Price / Sales0.01
Cash FlowN/A
Price / CashN/A
Book Value($79.74) per share
Price / Book0.00

Profitability

Trailing EPS($165.69)
Net Income$-32,610,000.00
Net Margins-1,918.71%
Return on EquityN/A
Return on Assets-1,232.10%

Miscellaneous

Employees116
Outstanding Shares5,640,000

Rennova Health (OTCMKTS:RNVA) Frequently Asked Questions

What is Rennova Health's stock symbol?

Rennova Health trades on the OTCMKTS under the ticker symbol "RNVA."

When did Rennova Health's stock split? How did Rennova Health's stock split work?

Shares of Rennova Health reverse split before market open on Friday, October 6th 2017. The 1-15 reverse split was announced on Friday, September 22nd 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 5th 2017. An investor that had 100 shares of Rennova Health stock prior to the reverse split would have 7 shares after the split.

How were Rennova Health's earnings last quarter?

Rennova Health Inc (OTCMKTS:RNVA) released its earnings results on Monday, November, 20th. The company reported ($10.59) EPS for the quarter. The company had revenue of $1.41 million for the quarter. View Rennova Health's Earnings History.

When will Rennova Health make its next earnings announcement?

Rennova Health is scheduled to release their next quarterly earnings announcement on Tuesday, April, 10th 2018. View Earnings Estimates for Rennova Health.

Who are some of Rennova Health's key competitors?

Who are Rennova Health's key executives?

Rennova Health's management team includes the folowing people:

  • Seamus Lagan, President, Chief Executive Officer, Interim Chief Financial Officer, Director (Age 48)
  • John B. Beach, Director (Age 55)
  • Paul R. Billings M.D. Ph.D., Director (Age 63)
  • Christopher E. Diamantis, Director (Age 48)
  • James M. Karis, Director (Age 66)
  • Robert P. Lee, Director (Age 62)

How do I buy Rennova Health stock?

Shares of Rennova Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rennova Health's stock price today?

One share of Rennova Health stock can currently be purchased for approximately $0.01.

How big of a company is Rennova Health?

Rennova Health has a market capitalization of $31,584.00 and generates $5.24 million in revenue each year. The company earns $-32,610,000.00 in net income (profit) each year or ($165.69) on an earnings per share basis. Rennova Health employs 116 workers across the globe.

How can I contact Rennova Health?

Rennova Health's mailing address is 400 S Australian Ave Ste 800, WEST PALM BEACH, FL 33401-5045, United States. The company can be reached via phone at +1-561-8551626 or via email at [email protected]


MarketBeat Community Rating for Rennova Health (RNVA)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  36 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  82
MarketBeat's community ratings are surveys of what our community members think about Rennova Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Rennova Health (OTCMKTS:RNVA) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Rennova Health (OTCMKTS:RNVA) Earnings History and Estimates Chart

Earnings by Quarter for Rennova Health (OTCMKTS:RNVA)

Rennova Health (OTCMKTS RNVA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/10/2018N/AView Earnings Details
11/20/2017Q3 2017($10.59)$1.41 millionViewN/AView Earnings Details
8/15/2017Q2 2017($20.55)$0.90 millionViewN/AView Earnings Details
5/24/2017Q1 2017($152.17)$1.18 millionViewN/AView Earnings Details
11/14/2016Q316($15.00)($4.35)$5.89 million$0.29 millionViewN/AView Earnings Details
8/15/2016Q2 2016($76.54)$3.05 millionViewN/AView Earnings Details
5/16/2016Q116($2.10)$1.88 millionViewN/AView Earnings Details
8/14/2015Q2 2015($495.25)($585.29)$0.21 million$0.11 millionViewN/AView Earnings Details
2/13/2015($5.55)($5.70)ViewN/AView Earnings Details
11/13/2014($7.35)($5.25)$0.11 million$0.18 millionViewN/AView Earnings Details
8/14/2014Q214($7.35)($9.15)$0.06 million$0.06 millionViewN/AView Earnings Details
2/11/2014($7.35)($7.20)$0.06 millionViewN/AView Earnings Details
11/13/2013Q2($4.35)$0.25 millionViewN/AView Earnings Details
8/13/2013Q2 2013($1,575.79)$0.27 millionViewN/AView Earnings Details
6/3/2013Q1 2013($1,935.97)$0.28 millionViewN/AView Earnings Details
2/12/2013Q4 2012($2,881.44)ViewN/AView Earnings Details
11/14/2012Q213($10.20)ViewN/AView Earnings Details
8/14/2012Q2 2012($1,805.40)ViewN/AView Earnings Details
2/9/2012Q4 2011($1,598.30)ViewN/AView Earnings Details
11/10/2011Q3 2011($1,913.46)ViewN/AView Earnings Details
8/12/2011Q2 2011($2,642.82)ViewN/AView Earnings Details
2/14/2011Q4 2010($247.62)ViewN/AView Earnings Details
11/12/2010Q3 2010$360.18ViewN/AView Earnings Details
8/13/2010Q2 2010($6,573.29)ViewN/AView Earnings Details
6/11/2010Q1 2010($8,239.12)ViewN/AView Earnings Details
2/11/2010Q4 2009($2,543.77)ViewN/AView Earnings Details
11/12/2009Q3 2009($4,524.77)ViewN/AView Earnings Details
8/13/2009Q2 2009($6,978.49)ViewN/AView Earnings Details
6/25/2009Q1 2009($8,779.39)ViewN/AView Earnings Details
2/12/2009Q4 2008($4,164.58)ViewN/AView Earnings Details
11/13/2008Q3 2008($7,676.34)ViewN/AView Earnings Details
8/13/2008Q2 2008($2,476.24)ViewN/AView Earnings Details
6/16/2008Q1 2008$49,074.56ViewN/AView Earnings Details
2/5/2008Q4 2007$8,756.88ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Rennova Health (OTCMKTS:RNVA) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Rennova Health (OTCMKTS:RNVA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Rennova Health (OTCMKTS RNVA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 10.94%
Insider Trades by Quarter for Rennova Health (OTCMKTS:RNVA)

Rennova Health (OTCMKTS RNVA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/14/2016Jason AdamsCFOBuy1,160$0.28$324.801,725View SEC Filing  
7/14/2016Michael Louis GoldbergDirectorBuy2,500$0.28$700.007,110View SEC Filing  
7/14/2016Seamus LaganCEOBuy10,900$0.38$4,142.001,900View SEC Filing  
6/7/2016Jason AdamsCFOBuy270$0.75$202.50565View SEC Filing  
6/3/2016Jason AdamsCFOBuy295$0.63$185.85295View SEC Filing  
5/23/2016Michael Louis GoldbergDirectorBuy1,500$0.61$915.001,500View SEC Filing  
11/15/2013Carl MuscariDirectorBuy1,300$3.85$5,005.00View SEC Filing  
3/26/2013Carl MuscariDirectorBuy1,540$3.25$5,005.00View SEC Filing  
10/5/2012Participations Alcatel-LucentMajor ShareholderSell149,200$4.20$626,640.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Rennova Health (OTCMKTS RNVA) News Headlines

Source:

SEC Filings

Rennova Health (OTCMKTS:RNVA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Rennova Health (OTCMKTS:RNVA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Rennova Health (OTCMKTS RNVA) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.